4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

Purpose Genetic testing has advanced significantly since the publication of the 2011
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the …

This international multidisciplinary document intends to provide clinicians with evidence-
based practical patient-centered recommendations for evaluating patients and decedents …

Aims Genetic testing is recommended in specific inherited heart diseases but its role
remains unclear and it is not currently recommended in unexplained cardiac arrest (UCA) …

Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease and
defined by unexplained isolated progressive myocardial hypertrophy, systolic and diastolic …

In the early nineties, few years before the birth of Europace, the clinical and scientific world
of familial arrhythmogenic conditions was revolutionized by the identification of the first …

Sinus node dysfunction may be either transient (reversible/physiological) due to the
involvement of the autonomic nervous system or pharmaceuticals, or chronic due to …

Aims Recent studies have shown that in more than half of apparently unexplained sudden
cardiac arrests (SCA), a specific aetiology can be unmasked by a careful evaluation. The …

Background Genetic heart disease is a common cause of sudden cardiac arrest (SCA) in the
young and those without an ischaemic precipitant. Identifying a cause of SCA in these …

Background: Sudden cardiac arrest (SCA) and sudden unexplained death (SUD) are feared
sequelae of many genetic heart diseases. In rare circumstances, pathogenic variants in …